In Vivo Assessment of Antibody-Dependent Enhancement of Influenza B Infection.
Saved in:
| Title: | In Vivo Assessment of Antibody-Dependent Enhancement of Influenza B Infection. |
|---|---|
| Authors: | Rao GK; Department of Safety Assessment, Genentech, Inc., South San Francisco, California 94080., Prell RA; Department of Safety Assessment, Genentech, Inc., South San Francisco, California 94080., Laing ST; Department of Safety Assessment, Genentech, Inc., South San Francisco, California 94080., Burleson SCM; Burleson Research Technologies Inc., Morrisville, North Carolina 27560., Nguyen A; OMNI Biomarker Development., McBride JM; OMNI Biomarker Development., Zhang C; Preclinical and Translational Pharmacokinetics., Sheinson D; Biostatistics, Genentech, Inc., South San Francisco, California 94080., Halpern WG; Department of Safety Assessment, Genentech, Inc., South San Francisco, California 94080. |
| Source: | Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2019 Jun 01; Vol. 169 (2), pp. 409-421. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9805461 Publication Model: Print Cited Medium: Internet ISSN: 1096-0929 (Electronic) Linking ISSN: 10960929 NLM ISO Abbreviation: Toxicol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1096-0929 |
|---|---|
| DOI: | 10.1093/toxsci/kfz053 |
